We are live on ! Find out more
Belvedere Trading

Belvedere Trading Portfolio holdings

AUM $84.4B
1-Year Est. Return 52.68%
This Fund
S&P 500
This Quarter Est. Return
+21.44%
1 Year Est. Return
+52.68%
3 Year Est. Return
+262.56%
5 Year Est. Return
+468.62%
10 Year Est. Return
AUM
$80.6B
AUM Growth
+$3.31B
Cap. Flow
-$2.76B
Cap. Flow %
-3.43%
Top 10 Hldgs %
86.17%
Holding
990
New
330
Increased
137
Reduced
160
Closed
324

Sector Composition

Rank Sector Weight
1 Technology 1.24%
2 Consumer Discretionary 0.34%
3 Communication Services 0.13%
4 Industrials 0.01%
5 Energy 0.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMR icon
676
CALL
Alpha Metallurgical Resources
AMR
$1.77B
-700
Closed -$232K
AMR icon
677
PUT
Alpha Metallurgical Resources
AMR
$1.77B
-400
Closed -$132K
AMZU icon
678
Direxion Daily AMZN Bull 2X ETF
AMZU
$258M
-7,240
Closed -$251K
ANNX icon
679
CALL
Annexon
ANNX
$796M
-5,200
Closed -$37.3K
ANNX icon
680
Annexon
ANNX
$796M
-16,446
Closed -$118K
APEI icon
681
CALL
American Public Education
APEI
$940M
-18,000
Closed -$256K
APEI icon
682
American Public Education
APEI
$940M
-17,159
Closed -$244K
ARM icon
683
CALL
Arm
ARM
$240B
-100
Closed -$12.5K
ATLX icon
684
CALL
Atlas Lithium Corp
ATLX
$75.5M
-2,300
Closed -$39.1K
ATLX icon
685
Atlas Lithium Corp
ATLX
$75.5M
-23,844
Closed -$406K
ATLX icon
686
PUT
Atlas Lithium Corp
ATLX
$75.5M
-15,000
Closed -$255K
ATXS
687
CALL
DELISTED
Astria Therapeutics
ATXS
-16,500
Closed -$232K
ATXS
688
DELISTED
Astria Therapeutics
ATXS
-16,036
Closed -$226K
ATXS
689
PUT
DELISTED
Astria Therapeutics
ATXS
-8,500
Closed -$120K
AUPH icon
690
CALL
Aurinia Pharmaceuticals
AUPH
$1.95B
-10,500
Closed -$52.6K
AUPH icon
691
Aurinia Pharmaceuticals
AUPH
$1.95B
-4,497
Closed -$22.5K
AUPH icon
692
PUT
Aurinia Pharmaceuticals
AUPH
$1.95B
-6,700
Closed -$33.6K
AVEM icon
693
Avantis Emerging Markets Equity ETF
AVEM
$24.4B
-359
Closed -$20.8K
AVEM icon
694
PUT
Avantis Emerging Markets Equity ETF
AVEM
$24.4B
-10,000
Closed -$580K
AVIR icon
695
Atea Pharmaceuticals
AVIR
$370M
-10,519
Closed -$42.5K
BALY icon
696
CALL
Bally's
BALY
$708M
-1,300
Closed -$18.1K
BALY icon
697
Bally's
BALY
$708M
-16,346
Closed -$228K
BALY icon
698
PUT
Bally's
BALY
$708M
-10,700
Closed -$149K
BBAI icon
699
PUT
BigBear.ai
BBAI
$1.24B
-3,000
Closed -$6.15K
BCAB icon
700
BioAtla
BCAB
$5.34M
-235
Closed -$40.4K

Similar funds

Belvedere Trading's Q2 2024 Portfolio in Review

As of Q2 2024, Belvedere Trading held 990 positions worth $80.6B, up 4.3% from $77.3B the previous quarter. Its ten largest holdings account for 86% of the portfolio.

Belvedere Trading withdrew a net $2.76B in Q2 2024, closing 324 positions and reducing 160 holdings. Its most notable exit was iShares Russell 2000 ETF, an estimated $17.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 1.2% of assets, up from 0.8% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, Belvedere Trading opened a new position in Meta Platforms (Facebook) worth $101M.

  • Belvedere Trading's largest Q2 2024 buy was Meta Platforms (Facebook): 201,182 shares worth $101M.
  • Belvedere Trading added most to NVIDIA in Q2 2024, an estimated $141M increase.
  • Belvedere Trading's biggest Q2 2024 reduction was Apple, cutting an estimated $47.1M.
  • Belvedere Trading fully exited iShares Russell 2000 ETF in Q2 2024, selling an estimated $17.4M.
  • Belvedere Trading's ten largest holdings make up 86% of its $80.6B portfolio in Q2 2024.
  • Belvedere Trading opened 330 new positions and closed 324 in Q2 2024.
  • Belvedere Trading's portfolio value rose 4.3% quarter-over-quarter to $80.6B.

Based on Belvedere Trading's 13F filing for Q2 2024, filed 9 Aug 2024.